Headaches and Migraines

Recent FDA-approved medications have introduced new avenues for migraine relief and prevention. Zavegepant, Atogepant, and Symbravo stand out with innovative mechanisms targeting acute and chronic migraines. These advancements, including novel CGRP inhibitors and preventive options, offer hope for better quality of life. As research progresses, understanding these treatments becomes vital for both patients and healthcare […]